Department of Pediatrics, King George's Medical University, Lucknow, Uttar Pradesh, India.
Department of Microbiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
Vaccine. 2023 Oct 20;41(44):6619-6624. doi: 10.1016/j.vaccine.2023.09.029. Epub 2023 Sep 26.
Streptococcus pneumoniae is leading bacterial cause of community acquired pneumonia and according to World Health Organization, responsible for 14 % death in children. There is effective vaccine available against Streptococcus pneumoniae. Hence the primary objective was to isolate Streptococcus pneumoniae from nasopharyngeal swabs in children aged 2-59 months with and without community acquired pneumonia and to assess their serotypes.
This case-control study was conducted in tertiary teaching institutes in northern India. Hospitalized children, aged 2-59 months, with World Health Organization-defined community acquired pneumonia were included as cases. Age matched healthy controls were recruited from immunization clinic. All enrolments were done after written informed parental consent. Nasopharyngeal swabs were taken from both cases and controls, and were cultured on 5 % sheep blood agar with gentamycin plate for growth of Streptococcus pneumoniae and incubated in a jar at 37 for 18-24 hrs. Quellung reaction test was used for serotyping.
From March 2017 to December 2022, 2693 children (1910 cases and 783 controls), were recruited. The median age of cases was 7 months and controls 10 months. Almost all the cases had received antibiotics prior to hospitalization. Streptococcus pneumoniae positivity in nasopharyngeal swab was 8.1 % in cases, of which 56.8 % were vaccine serotypes and 23.6 % in controls, of which 37.8 % were vaccine serotypes. Adjusted odds ratio of isolating vaccine serotypes among cases as compared to controls was 1.77 (95 % CI, 1.09-2.88).
Streptococcus pneumoniae isolation from nasopharyngeal was found to be in lower proportion in cases as compared to control, though colonization with vaccine serotypes was higher in cases as compared to control. Therefore, pneumococcal vaccine coverage must be increased to prevent community acquired pneumonia.
肺炎链球菌是导致社区获得性肺炎的主要细菌性病因,根据世界卫生组织的数据,它导致 14%的儿童死亡。目前已有针对肺炎链球菌的有效疫苗。因此,主要目的是从 2-59 个月龄有和无社区获得性肺炎的儿童的鼻咽拭子中分离肺炎链球菌,并评估其血清型。
这是一项在印度北部三级教学医院进行的病例对照研究。纳入符合世界卫生组织定义的社区获得性肺炎的 2-59 个月龄住院患儿为病例,从免疫接种门诊招募年龄匹配的健康对照。所有入组均在获得书面知情父母同意后进行。从病例和对照中采集鼻咽拭子,接种于含 5%绵羊血和庆大霉素的琼脂平板上培养肺炎链球菌,在罐中于 37°C孵育 18-24 小时。采用胶乳凝集试验进行血清型鉴定。
2017 年 3 月至 2022 年 12 月,共纳入 2693 名儿童(1910 例病例和 783 例对照)。病例的中位年龄为 7 个月,对照为 10 个月。几乎所有病例在住院前均接受过抗生素治疗。鼻咽拭子中肺炎链球菌阳性率在病例中为 8.1%,其中 56.8%为疫苗血清型,在对照中为 23.6%,其中 37.8%为疫苗血清型。病例组与对照组相比,分离出疫苗血清型的调整优势比为 1.77(95%CI,1.09-2.88)。
与对照组相比,病例组中从鼻咽部分离出肺炎链球菌的比例较低,但病例组中与疫苗血清型的定植率高于对照组。因此,必须增加肺炎球菌疫苗的覆盖率,以预防社区获得性肺炎。